Key facts
- In December 2024, 146 measles cases were reported by 9 countries. Twelve countries reported zero cases.
- Through its epidemic intelligence activities, ECDC identified an additional 136 new cases in 2025 from seven EU countries.
- No measles-related deaths have been reported in recent months.
- There has been high measles activity overall in the EU/EEA over the last 12 months; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks, while others have reported no sustained or very low transmission.
- Outbreaks associated with imported measles cases have been reported by EU countries.
Overview
In December 2024, 146 measles cases were reported by 9 countries and zero cases by 12 countries. In the most recent 12-month period, from 1 January to 31 December 2024, 30 EU/EEA countries reported a total of 16 510 cases of measles. Between 1 January and 31 December 2024, of the 16 510 cases with known age, 7 066 (42.8%) cases were in children under five years old and 4 972 (30.1%) cases were in individuals aged 15 years or above.
The highest notification rates were observed in infants under one year of age (517.8 cases per million) and children aged 1-4 years (298.5 cases per million). Of 13 296 cases (100.0% of all cases) with a known age and vaccination status, 11 581 (87.1%) were unvaccinated, 1 101 (8.3%) were vaccinated with one dose of a measles-containing vaccine, 574 (4.3%) were vaccinated with two or more doses, and 25 (0.2%) were vaccinated with an unknown number of doses.
Ten deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (9) and Ireland (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance, with data collection conducted on 10 February 2025 from official public sources, with data collection conducted on 10 February 2025 from official public sources, identified 136 new measles cases reported in 2025. New cases were reported in seven EU countries: Austria (47), Czechia (6), Finland (1), Germany (26), Ireland (29), Lithuania (1), and the Netherlands (26). No measles-related deaths have been reported in recent months.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
In 2025, measles cases were reported in:
Austria reported 47 confirmed measles cases in 2025 and as of 5 February 2025.
Czechia reported six measles cases in 2025 and as of 3 February 2025.
Finland reported one measles case in 2025 and as of 10 February 2025.
Germany reported 26 measles cases in 2025 and as of 10 February 2025.
Ireland reported 29 measles cases in 2025 and as of 10 February 2025.
Lithuania reported one measles case in 2025 and as of 30 January 2025
Netherlands reported 26 measles cases in 2025 and as of 6 February 2025. In 2025, eleven cases were reported to have contracted measles in Morocco and three in Romania. Healthcare professionals in the Netherlands have been advised to be alert to measles in patients who have recently returned from an area where measles is prevalent.
Spain: on 16 January the Department of Health of the Basque Government reported measles outbreak associated with an imported case in Bizakia, with 12 confirmed measles cases. As of 7 February 2025, the number of measles cases associated with this outbreak has increased to 34, including 16 cases in healthcare workers. Staff, patients and visitors are recommended to take extreme preventive measures, such as masks, especially in emergency areas, and to remain alert to enable prompt diagnosis.
Epidemiological summary for select countries outside of EU/EEA with relevant epidemic intelligence updates:
Morocco
Morocco is experiencing a significant measles outbreak that began in October 2023 and has spread nationwide. According to media reports citing official sources, 3 631 measles cases and five deaths have been reported in 2025. In total over 24 474, including 116 deaths, have been reported since the beginning of the outbreak and as of 23 January 2025.
The increase in measles cases is attributed to declining vaccination rates following the COVID-19 pandemic and vaccine hesitancy. However, according to the WHO data, between 2016 and 2023 Morocco reported 99% coverage of the first and second doses of measles vaccine.
Summary of measles cases reported by WHO regional offices
(The latest data available on WHO website as of 11 February 2025 was from January 2025 and was included in the last monthly update)
WHO Regional Office for Europe (WHO/EUROPE) reported 106 237 measles cases in 2024. The five non-EU/EEA countries reporting the most measles cases were: Kazakhstan (28 066), Russian Federation (21 682), Azerbaijan (16 685), Kyrgyzstan (13 203), and the United Kingdom (2 915).
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
WHO Regional Office for Africa (WHO AFRO) has reported 59 358 measles cases in 2024. The highest numbers of cases were reported from Ethiopia (28 139), Nigeria (10 237), Burkina Faso (7 147), Cote d’Ivoire (6 464) and the Democratic Republic of the Congo (4 489).
WHO Regional Office for the Americas (WHO PAHO) has reported 455 measles cases in 2024. Most cases were reported from the United States (284) and Canada (141).
WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 90 007 measles cases in 2024. The highest numbers of cases were reported from Iraq (32 179), Pakistan (23 596), Yemen (19 988), Afghanistan (9 596) and Somalia (1 303).
WHO Regional Office for South-East Asia (WHO SEARO) has reported 32 838 measles cases in 2024. The highest numbers of cases were reported from India (19 852), Thailand (7 507), Indonesia (4 718), Sri Lanka (296), and Nepal (222).
WHO Regional Office for the Western Pacific (WHO WPRO) has reported 10 484 measles cases in 2024. The following five countries reported the most cases: the Philippines (3 985), Malaysia (3 904), Viet Nam (1 408), China (1 026), and Australia (48).
ECDC assessment
The overall number of measles cases in the EU/EEA steadily increased between June 2023 and March 2024 before decreasing between April 2024 and December 2024. in December 2024, a slight decrease in case numbers compared with November 2024 was observed. Measles cases may continue to increase in the EU/EEA in the coming months. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.